Natural killer cells in antitumour adoptive cell immunotherapy

TJ Laskowski, A Biederstädt, K Rezvani - Nature Reviews Cancer, 2022 - nature.com
Natural killer (NK) cells comprise a unique population of innate lymphoid cells endowed with
intrinsic abilities to identify and eliminate virally infected cells and tumour cells. Possessing …

Natural killer cells: a promising immunotherapy for cancer

J Chu, F Gao, M Yan, S Zhao, Z Yan, B Shi… - Journal of translational …, 2022 - Springer
As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …

CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis

EC Lerner, KI Woroniecka, VM D'Anniballe… - Nature Cancer, 2023 - nature.com
The accepted paradigm for both cellular and anti-tumor immunity relies upon tumor cell
killing by CD8+ T cells recognizing cognate antigens presented in the context of target cell …

The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy

S Paul, G Lal - Frontiers in immunology, 2017 - frontiersin.org
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against
physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a …

Outlook for new CAR-based therapies with a focus on CAR NK cells: what lies beyond CAR-engineered T cells in the race against cancer

M Daher, K Rezvani - Cancer discovery, 2021 - AACR
Chimeric antigen receptor (CAR) engineering of T cells has revolutionized the field of
cellular therapy for the treatment of cancer. Despite this success, autologous CAR-T cells …

Natural killer cell engagers in cancer immunotherapy: next generation of immuno‐oncology treatments

O Demaria, L Gauthier, G Debroas… - European Journal of …, 2021 - Wiley Online Library
Immuno‐oncology is revolutionizing the treatment of cancers, by inducing the recognition
and elimination of tumor cells by the immune system. Recent advances have focused on …

[HTML][HTML] STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation

E Masle-Farquhar, KJL Jackson, TJ Peters, G Al-Eryani… - Immunity, 2022 - cell.com
The association between cancer and autoimmune disease is unexplained, exemplified by T
cell large granular lymphocytic leukemia (T-LGL) where gain-of-function (GOF) somatic …

From CAR-T cells to CAR-NK cells: a developing immunotherapy method for hematological malignancies

H Lu, X Zhao, Z Li, Y Hu, H Wang - Frontiers in Oncology, 2021 - frontiersin.org
The approval of CD19 chimeric antigen receptor (CAR)-engineered T (CAR-T) cell products
in B-cell malignancies represents a breakthrough in CAR-T cell immunotherapy. However …

CAR-NK cells in the treatment of solid tumors

E Wrona, M Borowiec, P Potemski - International journal of molecular …, 2021 - mdpi.com
CAR-T (chimeric antigen receptor T) cells have emerged as a milestone in the treatment of
patients with refractory B-cell neoplasms. However, despite having unprecedented efficacy …

Controlling natural killer cell responses: integration of signals for activation and inhibition

EO Long, H Sik Kim, D Liu, ME Peterson… - Annual review of …, 2013 - annualreviews.org
Understanding how signals are integrated to control natural killer (NK) cell responsiveness
in the absence of antigen-specific receptors has been a challenge, but recent work has …